ALK-Abelló A/S

General ticker "AKBLF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $5.7B (TTM average)

ALK-Abelló A/S follows the US Stock Market performance with the rate: 40.6%.

Estimated limits based on current volatility of 0.5%: low 31.22$, high 31.54$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2026-03-18, amount 0.18$ (Y0.57%)

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [28.01$, 45.81$]
  • 2026-12-31 to 2027-12-31 estimated range: [27.44$, 45.25$]

Similar symbols

Short-term AKBLF quotes

Long-term AKBLF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue DKK4,824.00MM DKK5,537.00MM DKK6,297.70MM
Operating Expenses DKK4,158.00MM DKK4,446.00MM DKK4,638.47MM
Operating Income DKK666.00MM DKK1,091.00MM DKK1,659.23MM
Non-Operating Income DKK-19.00MM DKK-34.00MM DKK-27.94MM
Interest Expense DKK22.00MM DKK65.00MM DKK27.94MM
R&D Expense DKK618.00MM DKK531.00MM DKK594.65MM
Income(Loss) DKK647.00MM DKK1,057.00MM DKK1,631.30MM
Taxes DKK161.00MM DKK242.00MM DKK437.01MM
Profit(Loss)* DKK486.00MM DKK815.00MM DKK1,194.29MM
Stockholders Equity DKK4,447.00MM DKK5,373.00MM DKK6,430.40MM
Inventory DKK1,423.00MM DKK1,716.00MM DKK1,778.96MM
Assets DKK6,726.00MM DKK8,246.00MM DKK9,151.22MM
Operating Cash Flow DKK667.00MM DKK1,213.00MM DKK1,812.88MM
Capital expenditure DKK379.00MM DKK1,303.00MM DKK275.37MM
Investing Cash Flow DKK-375.00MM DKK-1,417.00MM DKK-384.13MM
Financing Cash Flow DKK-31.00MM DKK310.00MM DKK-758.28MM
Earnings Per Share** DKK2.20 DKK3.68 DKK5.39

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.